Table 1.
Conc. | IRR | [95% CI] | P value |
---|---|---|---|
70 | 5.7 | [4.2–7.7] | < 0.0001 |
65 | 5.0 | [3.8–6.4] | < 0.0001 |
60 | 4.7 | [3.6–6.1] | < 0.0001 |
50 | 4.1 | [3.3–5.0] | < 0.0001 |
45 | 2.6 | [2.0–3.4] | < 0.0001 |
40 | 3.0 | [2.4–3.7] | < 0.0001 |
35 | 2.1 | [1.6–2.7] | < 0.0001 |
30 | 2.4 | [1.9–3.1] | < 0.0001 |
25 | 2.0 | [1.4–2.8] | < 0.0001 |
20 | 1.6 | [1.3–2.1] | < 0.0001 |
15 | 1.2 | [0.9–1.6] | 0.27 |
12 | 0.5 | [0.3–0.9] | 0.018 |
10 | 0.9 | [0.6–1.3] | 0.567 |
8 | 0.4 | [0.2–0.7] | 0.004 |
4 | 0.4 | [0.2–0.7] | 0.002 |
Conc. concentration of ivermectin imbibed in ng/ml, IRR incidence rate ratio of mortality at day 7 between each treatment group divided by the control group, 95% CI 95% confidence intervals
Significant P values (P < 0.05) are in italic